C32H49NO9
Neat
591.74
Room Temperature
CEVADINE; veratrine; Cevadin; 62-59-9; ERQ7M6C50B; Cevane-3, 4, 12, 14, 16, 17, 20-heptol, 4, 9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z), 4alpha, 16beta)-; NSC-93767; [(1R, 2S, 6S, 9S, 10R, 11S, 12S, 14R, 15S, 18S, 19S, 22S, 23S, 25R)-1, 10, 11, 12, 14, 23-hexahydroxy-6, 10, 19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02, 11.04, 9.015, 25.018, 23.019, 25]hexacosan-22-yl] (Z)-2-methylbut-2-enoate; Cevane-3beta, 4beta, 12, 14, 16beta, 17, 20-heptol, 4, 9-epoxy-, 3-(2-methylcrotonate), (Z)-; DTXSID4058237; Cevane-3, 4, 12, 14, 16, 17, 20-heptol, 4, 9-epoxy-, 3-((2Z)-2-methyl-2-butenoate), (3beta, 4alpha, 16beta)-; ((1R, 2S, 6S, 9S, 10R, 11S, 12S, 14R, 15S, 18S, 19S, 22S, 23S, 25R)-1, 10, 11, 12, 14, 23-hexahydroxy-6, 10, 19-trimethyl-24-oxa-4-azaheptacyclo(12.12.0.02, 11.04, 9.015, 25.018, 23.019 and 25)hexacosan-22-yl) (Z)-2-methylbut-2-enoate; RefChem:193963; DTXSID2034887; DTXCID901767935; 200-545-6; Cevadene; Veratrine (crystallized); NSC 93767; 8051-02-3
[(1R, 2S, 6S, 9S, 10R, 11S, 12S, 14R, 15S, 18S, 19S, 22S, 23S, 25R)-1, 10, 11, 12, 14, 23-hexahydroxy-6, 10, 19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02, 11.04, 9.015, 25.018, 23.019 and 25]hexacosan-22-yl] (Z)-2-methylbut-2-enoate
InChI=1S/C32H49NO9/c1-6-18(3)25(35)41-24-11-12-26(4)19-8-9-20-28(37)13-23(34)31(39)21(29(28,38)16-30(20,26)42-32(19,24)40)15-33-14-17(2)7-10-22(33)27(31,5)36/h6,17,19-24,34,36-40H,7-16H2,1-5H3/b18-6-/t17-,19-,20-,21-,22-,23-,24-,26-,27+,28+,29+,30+,31-,32-/m0/s1